These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1538 related articles for article (PubMed ID: 14500399)
1. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399 [TBL] [Abstract][Full Text] [Related]
2. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Schultz ES; Lethé B; Cambiaso CL; Van Snick J; Chaux P; Corthals J; Heirman C; Thielemans K; Boon T; van der Bruggen P Cancer Res; 2000 Nov; 60(22):6272-5. PubMed ID: 11103782 [TBL] [Abstract][Full Text] [Related]
3. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide. van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809 [TBL] [Abstract][Full Text] [Related]
4. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells. Zhang Y; Renkvist N; Sun Z; Schuler-Thurner B; Glaichenhaus N; Schuler G; Boon T; van der Bruggen P; Colau D Eur J Immunol; 2005 Apr; 35(4):1066-75. PubMed ID: 15756643 [TBL] [Abstract][Full Text] [Related]
5. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles. Kobayashi H; Song Y; Hoon DS; Appella E; Celis E Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551 [TBL] [Abstract][Full Text] [Related]
6. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. Mandic M; Almunia C; Vicel S; Gillet D; Janjic B; Coval K; Maillere B; Kirkwood JM; Zarour HM Cancer Res; 2003 Oct; 63(19):6506-15. PubMed ID: 14559844 [TBL] [Abstract][Full Text] [Related]
7. Identification of T cell epitopes by the use of rapidly generated mRNA fragments. Britten CM; Meyer RG; Graf C; Huber C; Wölfel T J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199 [TBL] [Abstract][Full Text] [Related]
8. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775 [TBL] [Abstract][Full Text] [Related]
9. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041 [TBL] [Abstract][Full Text] [Related]
10. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893 [TBL] [Abstract][Full Text] [Related]
11. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. Bonehill A; Heirman C; Tuyaerts S; Michiels A; Breckpot K; Brasseur F; Zhang Y; Van Der Bruggen P; Thielemans K J Immunol; 2004 Jun; 172(11):6649-57. PubMed ID: 15153480 [TBL] [Abstract][Full Text] [Related]
12. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311 [TBL] [Abstract][Full Text] [Related]
13. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380 [TBL] [Abstract][Full Text] [Related]
15. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017 [TBL] [Abstract][Full Text] [Related]
16. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
17. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells. Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319 [TBL] [Abstract][Full Text] [Related]
19. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
20. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells. Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]